Literature DB >> 9580846

Pharmacologic treatment of exercise-induced asthma.

B W Smith1, M LaBotz.   

Abstract

Exercise-induced asthma (EIA) is a complex disorder affecting a sizeable minority of athletes. Proper pharmacologic management allows most every athlete at any level to participate with EIA. This article briefly addresses the pathophysiology, diagnosis, and basic treatment principles, including nonpharmacologic management for EIA. Most of the article details the current treatment strategies and provides information on experimental treatments being investigated. In addition, ergogenic concerns and problems in treating elite athletes are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580846     DOI: 10.1016/s0278-5919(05)70085-5

Source DB:  PubMed          Journal:  Clin Sports Med        ISSN: 0278-5919            Impact factor:   2.182


  5 in total

Review 1.  Use of prescription drugs in athletes.

Authors:  Antti Alaranta; Hannu Alaranta; Ilkka Helenius
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

2.  National Athletic Trainers' Association position statement: management of asthma in athletes.

Authors:  Michael G Miller; John M Weiler; Robert Baker; James Collins; Gilbert D'Alonzo
Journal:  J Athl Train       Date:  2005 Jul-Sep       Impact factor: 2.860

3.  Asthma medications: basic pharmacology and use in the athlete.

Authors:  J E Houglum
Journal:  J Athl Train       Date:  2000-04       Impact factor: 2.860

Review 4.  Allergy and sports.

Authors:  S R Del Giacco; P E Manconi; G S Del Giacco
Journal:  Allergy       Date:  2001-03       Impact factor: 13.146

5.  Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist.

Authors:  James P Kemp
Journal:  Ther Clin Risk Manag       Date:  2009       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.